Corient Private Wealth LLC Has $1.35 Million Holdings in MKS Inc. $MKSI

Corient Private Wealth LLC cut its holdings in MKS Inc. (NASDAQ:MKSI) by 69.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,627 shares of the scientific and technical instruments company’s stock after selling 30,889 shares during the period. Corient Private Wealth LLC’s holdings in MKS were worth $1,354,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of MKSI. MAI Capital Management raised its position in shares of MKS by 12.5% during the second quarter. MAI Capital Management now owns 956 shares of the scientific and technical instruments company’s stock valued at $95,000 after buying an additional 106 shares during the last quarter. ProShare Advisors LLC grew its holdings in shares of MKS by 1.1% in the 2nd quarter. ProShare Advisors LLC now owns 10,964 shares of the scientific and technical instruments company’s stock worth $1,089,000 after purchasing an additional 114 shares during the last quarter. Optimum Investment Advisors increased its holdings in shares of MKS by 25.0% during the second quarter. Optimum Investment Advisors now owns 625 shares of the scientific and technical instruments company’s stock worth $62,000 after buying an additional 125 shares in the last quarter. EP Wealth Advisors LLC increased its holdings in MKS by 4.4% during the 2nd quarter. EP Wealth Advisors LLC now owns 3,620 shares of the scientific and technical instruments company’s stock valued at $360,000 after purchasing an additional 154 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in shares of MKS by 65.1% during the second quarter. Geneos Wealth Management Inc. now owns 652 shares of the scientific and technical instruments company’s stock valued at $65,000 after purchasing an additional 257 shares during the last quarter. Institutional investors own 99.79% of the company’s stock.

MKS Trading Up 0.2%

NASDAQ:MKSI opened at $163.19 on Thursday. The stock has a market capitalization of $10.96 billion, a PE ratio of 39.61, a price-to-earnings-growth ratio of 1.67 and a beta of 1.93. The company has a current ratio of 2.86, a quick ratio of 1.81 and a debt-to-equity ratio of 1.64. The firm’s 50 day moving average is $150.69 and its 200 day moving average is $122.66. MKS Inc. has a 12 month low of $54.84 and a 12 month high of $170.37.

MKS (NASDAQ:MKSI) last issued its quarterly earnings data on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The business had revenue of $988.00 million for the quarter, compared to analysts’ expectations of $963.87 million. During the same quarter in the prior year, the firm posted $1.72 EPS. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Sell-side analysts expect that MKS Inc. will post 6.94 earnings per share for the current year.

MKS Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 24th were issued a $0.22 dividend. This represents a $0.88 annualized dividend and a yield of 0.5%. The ex-dividend date was Monday, November 24th. MKS’s dividend payout ratio (DPR) is presently 21.36%.

Insider Transactions at MKS

In other MKS news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total transaction of $47,643.00. Following the completion of the sale, the director directly owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. This represents a 1.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jacqueline F. Moloney sold 300 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $122.14, for a total transaction of $36,642.00. Following the sale, the director owned 11,562 shares in the company, valued at approximately $1,412,182.68. The trade was a 2.53% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.57% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have issued reports on MKSI. Morgan Stanley restated an “overweight” rating and set a $151.00 target price on shares of MKS in a report on Monday, October 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $200.00 price target on shares of MKS in a research report on Tuesday, December 16th. Wall Street Zen upgraded shares of MKS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, September 20th. Needham & Company LLC lifted their price target on MKS from $136.00 to $170.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Finally, Citigroup increased their target price on MKS from $122.00 to $185.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. Eight analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $171.10.

MKS Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.